SVB Securities Downgrades VectivBio (NASDAQ:VECT) to Market

VectivBio (NASDAQ:VECT – Get Rating) was downgraded by stock analysts at SVB Securities from an “outperform” rating to a “market perform” rating in a research report issued on Tuesday, The Fly reports. VECT has been the topic of a number of other research reports. Piper Sandler boosted their price target on shares of VectivBio from […]

Related Keywords

Piper Sandler , Vr Adviser , Credit Suisse Group , Vivo Capital , Vectivbio Company Profile , Frazier Life Sciences Management , Driehaus Capital Management , Vectivbio Holding , Marshall Wace , Get Rating , Suisse Group , Capital Management , Vectivbio Daily , Vectivbio , Nasdaq Vect , Evect , Medical , Downgrade , Svb Securities ,